{"changes":[],"country":"US","description":"Merlin Therapeutics develops therapies targeting genetic defects in neurofibromatosis type 2 (NF2), a rare disorder driving benign nervous-system tumours. It works toward treatments for NF2 patients across the disease's lifecycle. The company frames its mission as pursuing every viable therapeutic angle for the disorder.","domain":"merlintherapeutics.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","investors":[],"lat":40.094763,"lng":-75.385133,"location":"king of prussia, pa, usa","name":"MERLIN THERAPEUTICS INC","rounds":[{"amountQuarantined":false,"amountUsd":1300000,"currency":"USD","date":"2025-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"merlintherapeutics-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"merlintherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://merlintherapeutics.com"},{"fact":"description","publisher":"merlintherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://merlintherapeutics.com"}],"stage":null,"techStack":["Nginx","Jetpack","jQuery Migrate","web-vitals","WordPress","WordPress Block Editor","WordPress.com","PHP","MySQL","jquery 3.7.1"],"totalRaisedUsd":1300000,"updatedAt":"2026-05-07"}